Cargando…
Improving Patients’ Life Quality after Radiotherapy Treatment by Predicting Late Toxicities
SIMPLE SUMMARY: Over 50% of patients with cancer will receive radiotherapy treatment. Five to ten percent of patients who received radiotherapy will develop side effects. Identifying these patients before treatment start would allow for treatment modification to minimize these effects and improve th...
Autores principales: | Lapierre, Ariane, Bourillon, Laura, Larroque, Marion, Gouveia, Tiphany, Bourgier, Céline, Ozsahin, Mahmut, Pèlegrin, André, Azria, David, Brengues, Muriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099838/ https://www.ncbi.nlm.nih.gov/pubmed/35565227 http://dx.doi.org/10.3390/cancers14092097 |
Ejemplares similares
-
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity
por: Lacombe, Jérôme, et al.
Publicado: (2019) -
One Size Fits All: Does the Dogma Stand in Radiation Oncology?
por: Azria, David, et al.
Publicado: (2016) -
Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology
por: Bourgier, Céline, et al.
Publicado: (2010) -
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
por: Azria, David, et al.
Publicado: (2018) -
Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity
por: Talbot, Christopher J., et al.
Publicado: (2019)